# A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00691405** · PHASE2 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 215 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Arformoterol tartrate inhalation solution
- **DRUG:** Arformoterol tartrate inhalation solution
- **DRUG:** Arformoterol tartrate inhalation solution
- **DRUG:** Placebo
- **DRUG:** Arformoterol tartrate inhalation solution
- **DRUG:** Arformoterol tartrate inhalation solution
- **DRUG:** Arformoterol tartrate inhalation solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00691405
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2004-05
- **Final completion:** 2004-05
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691405, "A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00691405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*